Counting Episodes — Establishing the Annual Baseline
Placeholder: baseline count anchors all downstream cycling calculations.
- ≥4: Episodes/year (DSM cut) (Placeholder short caption)
- 1–2/yr: Typical bipolar I rate (Placeholder short caption)
- ~15–20%: Rapid cyclers, all bipolar (Placeholder short caption)
- ~70%: Female predominance (Placeholder short caption)
Defining the episode-counting window
Placeholder: episodes tallied over trailing twelve months per DSM criteria.
Placeholder: mania, hypomania, depression, and mixed states all count.
Placeholder: distinct episodes require partial remission or polarity switch.
Antidepressants as a Cycle-Acceleration Trigger
Placeholder: antidepressant monotherapy can shorten inter-episode intervals.
- ~20–40%: Switch risk (unopposed AD) (Placeholder short caption)
- Common: Cycle acceleration cases (Placeholder short caption)
- Taper: Recommended action (Placeholder short caption)
- Mood stabilizer: Preferred alternative (Placeholder short caption)
Mechanism of antidepressant-induced cycling
Placeholder: monoaminergic activation destabilizes circadian mood regulation.
Placeholder: risk rises with tricyclics more than modern agents.
Placeholder: discontinuation often part of stabilization protocol.
Thyroid Axis Dysfunction and Mood Instability
Placeholder: hypothyroidism is strongly linked to rapid cycling presentations.
- ~30%: Rapid cyclers with hypothyroidism (Placeholder short caption)
- ~20%: Lithium-induced hypothyroidism (Placeholder short caption)
- TSH q6-12mo: Recommended monitoring (Placeholder short caption)
- Often: Correction improves cycling (Placeholder short caption)
Thyroid-mood axis interaction
Placeholder: subclinical and overt hypothyroidism both worsen cycling.
Placeholder: lithium therapy itself can induce thyroid dysfunction.
Placeholder: thyroid correction is a first-line stabilization step.
Crossing the ≥4 Episodes/Year Threshold
Placeholder: threshold crossing reclassifies course as rapid cycling specifier.
- ≥4/yr: DSM-5 threshold (Placeholder short caption)
- <24–48h: Ultradian cycling (Placeholder short caption)
- Worse: Prognosis vs standard course (Placeholder short caption)
- Higher: Treatment resistance (Placeholder short caption)
Clinical significance of the threshold
Placeholder: threshold triggers specifier coding and treatment escalation.
Placeholder: combined triggers push patients well past the cutoff.
Placeholder: early recognition limits long-term functional decline.
Flattening the Curve — Stabilization Strategies
Placeholder: combined pharmacologic and lifestyle strategies dampen oscillation.
- Lithium/valproate: First-line agents (Placeholder short caption)
- Avoid/taper: Antidepressant policy (Placeholder short caption)
- Levothyroxine: Thyroid correction (Placeholder short caption)
- Euthymia: Remission target (Placeholder short caption)
Multimodal stabilization protocol
Placeholder: mood stabilizer optimization forms the treatment backbone.
Placeholder: removing antidepressants and correcting thyroid reduce triggers.
Placeholder: sleep and rhythm regulation support long-term remission.
Placeholder: combined trigger removal plus stabilizer flattens the cycle.